GSA CAPITAL PARTNERS LLP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 8.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$679,000
-16.1%
52,700
-1.0%
0.07%
-25.8%
Q4 2018$809,000
-52.6%
53,241
-37.5%
0.09%
-1.1%
Q3 2018$1,705,000
+55.7%
85,244
+51.8%
0.09%
+74.1%
Q2 2018$1,095,000
-17.8%
56,144
-44.2%
0.05%
-33.3%
Q4 2017$1,332,000
-45.8%
100,561
-24.5%
0.08%
-51.8%
Q3 2017$2,459,000
+43.7%
133,270
+43.3%
0.17%
+50.0%
Q2 2017$1,711,000
+62.2%
93,000
+98.7%
0.11%
+96.5%
Q1 2017$1,055,000
-7.3%
46,800
+43.1%
0.06%
-16.2%
Q4 2016$1,138,000
+37.1%
32,708
-3.4%
0.07%
+51.1%
Q3 2016$830,000
+262.4%
33,860
+254.2%
0.04%
+246.2%
Q2 2016$229,000
-14.2%
9,560
-16.1%
0.01%
-23.5%
Q1 2016$267,000
-76.4%
11,400
-60.0%
0.02%
-69.6%
Q3 2015$1,131,000
-39.1%
28,465
+5.8%
0.06%
-21.1%
Q2 2015$1,858,000
+128.0%
26,898
+80.4%
0.07%
+121.9%
Q1 2015$815,000
+177.2%
14,910
+116.2%
0.03%
+52.4%
Q4 2014$294,000
+3.9%
6,896
-52.8%
0.02%
+5.0%
Q1 2014$283,000
-21.8%
14,615
-2.0%
0.02%
-31.0%
Q4 2013$362,00014,9150.03%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,921,550$81,254,0004.00%
Palo Alto Investors LP 1,614,536$33,453,0002.49%
Ghost Tree Capital, LLC 100,000$2,072,0001.46%
March Altus Capital Management LP 146,418$3,034,0001.11%
IRONWOOD INVESTMENT MANAGEMENT LLC 296,458$6,143,0000.98%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 999,339$20,706,0000.83%
Visium Asset Management, LP 2,070,870$42,908,0000.67%
AlphaOne Investment Services, LLC 97,448$2,019,0000.54%
CONTINENTAL ADVISORS LLC 57,438$1,190,0000.28%
Tamarack Capital Management, LLC 64,080$1,222,0000.25%
View complete list of AMAG PHARMACEUTICALS INC shareholders